Oncolinc Therapeutics Inc.

Oncolinc Therapeutics is a pharmaceutical company pioneering a first-in-class approach to overcome immune resistance in cancer and improve patient survival. Oncolinc’s lead therapeutic silences a recently discovered long non-coding RNA (lncRNA) molecule that enables cancer cells to hide from the immune system. By silen

Oncolinc Therapeutics Inc. is a company in prime.

Profile

Oncolinc Therapeutics is a pharmaceutical company pioneering a first-in-class approach to overcome immune resistance in cancer and improve patient survival. Oncolinc’s lead therapeutic silences a recently discovered long non-coding RNA (lncRNA) molecule that enables cancer cells to hide from the immune system. By silencing this lncRNA, the therapy restores immune recognition and has the potential […]

Its activity falls under prime; the profile below is assembled from public directory data.

It is recorded at the Creative Destruction Lab alumni company stage.

Website: oncolinc.com